Sökning: "vasoactive drugs"
Visar resultat 1 - 5 av 16 avhandlingar innehållade orden vasoactive drugs.
1. The gastrointestinal tract in cardiac anaesthesia and intensive care : Clinical and experimental studies
Sammanfattning : Gastrointestinal (GI) complications after cardiac surgery have a substantial impact on outcome. The aims were to investigate the frequency of, and methods for detecting, GI dysfunction after cardiac surgery and its relation to outcome, and the impact of vasoactive drugs on the GI tract in experimental cardiogenic shock. LÄS MER
2. Assessment of microvascular effects of vasoactive drugs : Methodological in vivo studies in humansbased on iontophoresis
Sammanfattning : Cardiovascular disease is the leading cause of death in western societies and endothelial dysfunction is one of the earliest signs seen in the development of such conditions. Thedevelopment of prognostic tools to aid in the prediction of micro- and macrovascular diseasebased on assessment of vascular reactivity is therefore of paramount importance. LÄS MER
3. Effects of burns and vasoactive drugs on human skin : Clinical and Experimental studies using microdialysis
Sammanfattning : Patients who require critical care, including those with burns, are affected by a systemic inflammatory reaction, which at times has consequences such as multiple organ dysfunction and failure. It has become increasingly evident that other factors important in the development of organ dysfunction are disturbances at the tissue level, in the microcirculation. LÄS MER
4. Arterial pulse wave analysis. With special reference to vasoactive and anaesthetic drugs and to heart lung interactions
Sammanfattning : In the young systolic arterial pressures (SAP) are higher in the radial artery than in the proximal aorta. Due to increased large artery stiffness and early pulse wave reflection aortic SAP increases more with age than peripheral SAP. LÄS MER
5. Studies on anti-inflammatory and vasoactive effects of mPGES-1 inhibition
Sammanfattning : Inflammation is the basis for various serious illnesses such as rheumatic diseases, cardiovascular diseases, and cancer. Prostaglandin E2 (PGE2) is a pro-inflammatory lipid mediator produced by cyclooxygenases (COX1/2) and the microsomal prostaglandin E synthase 1 (mPGES-1). LÄS MER